Antibodies to platelets in patients with anti-phospholipid antibodies.

Binding of anti-phospholipid antibodies to circulating platelets and its consequences on platelet activation and aggregation was investigated in 11 patients with anti-phospholipid antibodies. Seven patients had mild thrombocytopenia. Nine healthy donors served as controls. Binding to platelets was investigated by performing enzyme-linked immunosorbent assays (ELISAs) with phospholipids as antigen on platelet eluates. Platelet activation was measured by flow cytofluorometry using monoclonal antibodies to an activation-specific lysosomal membrane protein. Findings in ELISA were compared with results of a conventional immunofluorescence method to detect platelet autoantibodies. In seven patients antibodies to negatively charged phospholipids were present in platelet eluates. In all thrombocytopenic patients and controls the platelets were not activated and aggregation was not impaired. There was a positive concordance of 50% between the results of immunofluorescence and ELISA. No apparent relation was found between the results of ELISA or immunofluorescence and platelet counts. It is concluded that anti-phospholipid antibodies can bind to circulating platelets. This binding is not associated with measurable aggregation abnormalities nor with platelet activation characterized by exposure of lysosomal membrane proteins. More studies are necessary to determine the exact role of anti-phospholipid antibodies in the pathogenesis of thrombocytopenia and thrombosis.

[1]  P. D. de Groot,et al.  Crossreactivity of Antibodies Directed against Cardiolipin, DNA, Endothelial Cells and Blood Platelets , 1990, Thrombosis and Haemostasis.

[2]  G. Hughes,et al.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. , 1988, Annals of the rheumatic diseases.

[3]  D. Alarcón-Segovia,et al.  Pathogenetic potential of antiphospholipid antibodies. , 1988, The Journal of rheumatology.

[4]  P. D. de Groot,et al.  Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. , 1988, Annals of the rheumatic diseases.

[5]  L. Kater,et al.  Lupus anticoagulant: revival of an old phenomenon. , 1985, Clinical and experimental rheumatology.

[6]  G. Hughes,et al.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody , 1985, British journal of haematology.

[7]  M. Frojmovic,et al.  Microscopic measurements of platelet aggregation reveal a low ADP-dependent process distinct from turbidometrically measured aggregation. , 1983, The Journal of laboratory and clinical medicine.

[8]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[9]  C. J. Oss,et al.  Elution of Granulocyte and Platelet Antibodies , 1982, Vox sanguinis.

[10]  F. Helmerhorst,et al.  Autoimmune Thrombocytopenia: Detection of Platelet Autoantibodies with the Suspension Immunofluorescence Test , 1980, British journal of haematology.

[11]  J. Sixma,et al.  Detection of platelet activation using activation specific monoclonal antibodies. , 1990, Blood cells.

[12]  G. Hughes,et al.  Antiphospholipid antibodies--autoantibodies with a difference. , 1988, Annual review of medicine.

[13]  G. Hughes,et al.  Antiphospholipid Anti-Bodies—Autoantibodies with a Difference , 1988 .

[14]  J. V. van Oosterhout,et al.  Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. , 1987, Blood.

[15]  H. Hemker,et al.  Blood cell membranes and haemostasis. , 1982, Haemostasis.